<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896912453851</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896912453851</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cellular Metanephric Stromal Tumor in a Postmenopausal Woman</article-title>
<subtitle>A Case Report With Review of the Literature</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chaudhri</surname><given-names>Ali Aftab</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896912453851">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Lili</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896912453851">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Das</surname><given-names>Kasturi</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896912453851">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896912453851"><label>1</label>New York University Langone Medical Center, New York, NY, USA</aff>
<author-notes>
<corresp id="corresp1-1066896912453851">Ali A. Chaudhri, New York University Langone Medical Center, SRB 303, 522 First Avenue, New York, NY 10016, USA Email: <email>aliaftab.chaudhri@nyumc.org</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>21</volume>
<issue>2</issue>
<fpage>153</fpage>
<lpage>160</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Metanephric stromal tumor (MST) of the kidney is a rare pediatric neoplasm which has rarely been reported in adults. The authors present a case of MST, cellular type, an unreported variant, in a 56-year-old postmenopausal woman. The 9.0-cm tumor was solid, unencapsulated, and well circumscribed, with a firm homogeneous cut surface. The tumor was purely stromal with dense spindle-cell proliferations displaying prominent schwannoma-like architecture, intratumoral angiodysplasia, and entrapped native renal tubules with “onion-skin” tumor collarettes. The tumor stroma expressed CD34, estrogen, and progesterone and did not express desmin, smooth muscle actin, S-100, or TLE-1. Considering the characteristic morphology and immunophenotype, a diagnosis of “metanephric stromal tumor, cellular type,” was made. This is an exceptionally rare disease manifestation in an adult patient and the first description of MST with such high stromal cellularity, making this case unique in both clinical and pathological presentation.</p>
</abstract>
<kwd-group>
<kwd>metanephric</kwd>
<kwd>stromal</kwd>
<kwd>ovarian</kwd>
<kwd>angiodysplasia</kwd>
<kwd>onion skin</kwd>
<kwd>estrogen</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896912453851" sec-type="intro">
<title>Introduction</title>
<p>Metanephric stromal tumors (MSTs) have traditionally been described as a renal neoplasm with purely stromal elements limited to pediatric populations, with most cases presenting in the first 2 years of life.<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref></sup> In recent years, several cases of MST occurring in adults have been reported<sup><xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref><xref ref-type="bibr" rid="bibr3-1066896912453851"/>-<xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup> as well as cases of MST-like lesions with atypical features.<sup><xref ref-type="bibr" rid="bibr5-1066896912453851">5</xref></sup> We report a case of “metanephric stromal tumor, cellular type,” a novel variant of MST, presenting in a postmenopausal woman.</p>
</sec>
<sec id="section2-1066896912453851" sec-type="cases">
<title>Case Report</title>
<p>A 55-year-old, postmenopausal nulliparous female with a history of malignant melanoma in situ of the left forearm presented with lower abdominal pain. Computerized tomography revealed a focally low-enhancing, sharply circumscribed, central mass in the upper pole of the right kidney (<xref ref-type="fig" rid="fig1-1066896912453851">Figure 1A</xref>). She reported one instance of gross hematuria and denied any history of nephrolithiasis, voiding symptoms, bone pain, fever, weight loss, or change in appetite. Her medical history was negative for hypertension, and her family history was negative for renal disease. She was on a regimen of calcium supplementation and bisphosphonates for osteoporosis; no history of exogenous hormone use was provided. Urine analysis and chest X ray were negative.</p>
<fig id="fig1-1066896912453851" position="float">
<label>Figure 1.</label>
<caption>
<p>A. Computerized tomography of abdomen with intravenous contrast revealing a high attenuation mass in the right kidney (arrow). B. Macroscopic section showing a well-circumscribed, unencapsulated, tan, fibrous tumor with a well-demarcated interface with adjacent renal parenchyma (left). Macroscopic section demonstrating extension of tumor into perinephric adipose tissue, indicated by yellow ink (right). C. Intraoperative frozen section showing a spindle-cell proliferation with prominent schwannoma-like architecture and scattered epithelial appearing areas (200×, hematoxylin and eosin [H&amp;E]). D. Tumor infiltration into perinephric adipose tissue, corresponding to macroscopic observation (40×, H&amp;E)</p>
</caption>
<graphic xlink:href="10.1177_1066896912453851-fig1.tif"/></fig>
<p>The patient underwent a partial nephrectomy, which revealed a 9.0 × 5.5 × 3.5 cm<sup>3</sup> firm fibrotic mass that focally extended into perinephric adipose tissue and protruded into the renal pelvis, stretching the pelvis over the tumor. The cut surface was tan, firm, and fibrotic, with no areas of hemorrhage, necrosis, or cystic change, and demonstrated a well-demarcated tumor-renal interface (<xref ref-type="fig" rid="fig1-1066896912453851">Figure 1B</xref>). An intraoperative frozen section was performed to characterize the lesion because of its proximity to the renal pelvis, revealing a benign-appearing spindle-cell lesion with schwannoma-like morphology and rare epithelial appearing elements, initially suggesting a biphasic tumor (<xref ref-type="fig" rid="fig1-1066896912453851">Figure 1C</xref>).</p>
<p>Microscopic examination revealed an unencapsulated predominantly spindle-cell tumor involving the renal cortex and medulla with focal involvement of perinephric adipose tissue (<xref ref-type="fig" rid="fig1-1066896912453851">Figure 1D</xref>) and subtle infiltration into the adjacent uninvolved renal parenchyma (<xref ref-type="fig" rid="fig2-1066896912453851">Figures 2A</xref> and <xref ref-type="fig" rid="fig2-1066896912453851">2B</xref>). Varying degrees of cellularity in the tumor created a nodular appearance on low-power examination (<xref ref-type="fig" rid="fig2-1066896912453851">Figure 2C</xref>). The predominant component was stromal and consisted of a dense proliferation of hyperchromatic, plump spindle cells with minimal cytoplasm (ie, ovarian-type stroma), displaying schwannoma-like architecture (<xref ref-type="fig" rid="fig2-1066896912453851">Figure 2D</xref>). The sparse epithelial-appearing component consisted of nonneoplastic native renal tubules entrapped by hypocellular “onion-skin” tumor collarettes (<xref ref-type="fig" rid="fig3-1066896912453851">Figure 3A</xref>), with focal areas of proliferating stroma impinging entrapped tubules, resulting in a phyllodes-like growth pattern (<xref ref-type="fig" rid="fig3-1066896912453851">Figure 3B</xref>). Angiodysplasia of intratumoral arteries, previously described as epithelioid transformation of medial smooth muscle, was prominent throughout the tumor (<xref ref-type="fig" rid="fig3-1066896912453851">Figures 3C</xref> and <xref ref-type="fig" rid="fig3-1066896912453851">3D</xref>). No heterologous elements were present, nor were any neoplastic embryonal components identified. None of the entrapped renal tubules demonstrated juxtaglomerular hyperplasia.</p>
<fig id="fig2-1066896912453851" position="float">
<label>Figure 2.</label>
<caption>
<p>A. Subtly infiltrative border of the tumor with adjacent normal renal parenchyma (star; 100×, hematoxylin and eosin [H&amp;E]). B. Immunohistochemical stain for PAX-2, demonstrating entrapped dilated renal tubules (left) and adjacent normal renal parenchyma (right; 100×). C. Varying degrees of cellularity, casting a vaguely nodular appearance (40×, H&amp;E). D. Hypercellular area showing a dense cellular proliferation exhibiting schwannoma-like architecture (200×, H&amp;E) with strong nuclear expression of progesterone (left) and estrogen (right; 200×, inset)</p>
</caption>
<graphic xlink:href="10.1177_1066896912453851-fig2.tif"/></fig>
<fig id="fig3-1066896912453851" position="float">
<label>Figure 3.</label>
<caption>
<p>A. High-power view of perivascular onion skin collarette (single arrow) entrapped renal tubule with ovarian-type stroma (double arrow) and a tangential section of intratumoral angiodysplasia (arrowhead; 200×, hematoxylin and eosin [H&amp;E]). B. Phyllodes-like appearance of entrapped renal tubules mimicking mixed epithelial stromal tumor (100×, H&amp;E), with PAX-2 stain highlighting the nonneoplastic tubular epithelium (100×, inset). C. Section of perivascular nest with angiodysplasia of smooth muscle originating from the vascular wall (left); perivascular nests of proliferating smooth muscle mimicking epithelial nests (right; 200×, H&amp;E). D. CD34 stain (left) highlights the tumor stroma and endothelial cells, whereas stain for smooth muscle actin (right) highlights the islands of transformed smooth muscle cells of the vessel walls. Note the pinpoint lumen created by the perivascular nests of smooth muscle highlighted by the CD34 stain (200×)</p>
</caption>
<graphic xlink:href="10.1177_1066896912453851-fig3.tif"/></fig>
<p>Tumor cells were immunoreactive for antibodies to CD34 and vimentin, with negative reactivity for antibodies to desmin, Wilm’stumor 1 protein (WT-1), epithelial membrane antigen (EMA), B-Cell Lymphoma-2 protein (Bcl-2), CD31, Transducin-Like Enhancer 1 protein (TLE-1), Human Melanoma Black-45 protein (HMB45), S-100, or glial fibrillary acid protein (GFAP). Entrapped native renal tubules were highlighted by Paired boxed gene 2 protein (PAX-2), keratins 8/18 (CAM 5.2), and pankeratin (AE1/AE3). Tumor immunoreactivity for estrogen and progesterone was detected. Cytogenetic analysis of the tumor revealed a normal karyotype. After careful evaluation of tumor morphology and consultation with local experts, a diagnosis was made of “metanephric stromal tumor, cellular type,” arising in an adult—a previously unreported entity.</p>
</sec>
<sec id="section3-1066896912453851" sec-type="discussion">
<title>Discussion</title>
<p>MST is part of a spectrum of primary renal tumors known as the “metanephric tumor family,” which includes the purely epithelial metanephric adenoma (MA) and the biphasic metanephric adenofibroma (MAF).<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref>,<xref ref-type="bibr" rid="bibr6-1066896912453851">6</xref><xref ref-type="bibr" rid="bibr7-1066896912453851"/>-<xref ref-type="bibr" rid="bibr8-1066896912453851">8</xref></sup> Prior to the description of MST, the stromal component seen in MAF had been thought to be related to the stroma seen in congenital mesoblastic nephroma (CMN), resulting in purely stromal variants of MAF (ie, MST) being diagnosed as CMN.<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref>,<xref ref-type="bibr" rid="bibr8-1066896912453851">8</xref></sup> Criteria separating purely stromal variants of MAF from CMN, such as low-power nodular appearance, intratumoral angiodysplasia, and onion-skin tumor collarettes, introduced MST as a distinct tumor entity. MST would soon be thought of as representing one spectrum of neoplastic change with MA at the opposite end and MAF in between.<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref>,<xref ref-type="bibr" rid="bibr6-1066896912453851">6</xref>,<xref ref-type="bibr" rid="bibr8-1066896912453851">8</xref></sup> Though MAF and MA are known to occur in both children and adults,<sup><xref ref-type="bibr" rid="bibr6-1066896912453851">6</xref><xref ref-type="bibr" rid="bibr7-1066896912453851"/>-<xref ref-type="bibr" rid="bibr8-1066896912453851">8</xref></sup> MST is commonly seen in children younger than 2 years of age.<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref>,<xref ref-type="bibr" rid="bibr6-1066896912453851">6</xref><xref ref-type="bibr" rid="bibr7-1066896912453851"/>-<xref ref-type="bibr" rid="bibr8-1066896912453851">8</xref></sup> Some observations have led to the speculation that metanephric tumors may be related to Wilm’s tumor, possibly representing hyperdifferentiated forms.<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref>,<xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref>,<xref ref-type="bibr" rid="bibr7-1066896912453851">7</xref>,<xref ref-type="bibr" rid="bibr8-1066896912453851">8</xref></sup></p>
<p>The unusual, predominantly spindle-cell morphology of the tumor made it difficult to distinguish this case from a diverse group of spindle-cell tumors of the kidney, including schwannoma, synovial sarcoma, solitary fibrous tumor, and PEComa (perivascular epithelioid cell tumor). Considering the possibility that the epithelial appearing areas represented a well-differentiated neoplastic component and that the tumor was biphasic in nature, the differential was expanded to include MAF and mixed epithelial stromal tumor (MEST; <xref ref-type="table" rid="table1-1066896912453851">Table 1</xref>). With this differential in mind, a panel of immunohistochemical stains was performed. The stromal spindle cells diffusely expressed CD34, vimentin, estrogen, and progesterone and did not express desmin, WT-1, EMA, Bcl-2, CD31, TLE-1, HMB45, S-100, or GFAP. The majority of the epithelial appearing areas expressed smooth muscle actin, confirming their nature as smooth muscle proliferations characteristic of vascular angiodysplasia. The remaining areas, located mostly at the tumor-renal interface, expressed only PAX-2, CAM 5.2, and AE1/AE3, confirming their nature as nonneoplastic entrapped renal tubules. The immunophenotypic profile of the tumor is summarized in <xref ref-type="table" rid="table2-1066896912453851">Table 2</xref>. Ki-67 immunohistochemical stain showed a proliferation index of less than 1%, strongly supporting a benign nature. Cytogenetic analysis of the tumor revealed a normal karyotype.</p>
<table-wrap id="table1-1066896912453851" position="float">
<label>Table 1.</label>
<caption>
<p>Differential Diagnosis: Key Morphological and Immunohistochemical Features</p>
</caption>
<graphic alternate-form-of="table1-1066896912453851" xlink:href="10.1177_1066896912453851-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Metanephric Stromal Tumor</th>
<th align="center">Mixed Epithelial Stromal Tumor</th>
<th align="center">Metanephric Adenofibroma</th>
<th align="center">Intrarenal Schwannoma</th>
<th align="center">Solitary Fibrous Tumor</th>
<th align="center">Synovial Sarcoma</th>
<th align="center">PEComa (AML/AMLEC)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Morphology</td>
<td>Stromal proliferation with onion skin collarettes, angiodysplasia, entrapped native tubules, and JGH</td>
<td>Cystic and solid growth of benign mesenchymal and epithelial elements with phyllodes-like growth, no immature elements</td>
<td>Biphasic tumor with bland embryonal epithelium and MST-like stroma, and no blastema/immature elements</td>
<td>Encapsulated with mostly Antoni A areas (cellular stroma), and occasional Antoni B areas</td>
<td>Hypocellular and hypercellular stroma in “patternless pattern” with HPCT-like vasculature</td>
<td>Cystic tumor with short intersecting fascicles, necrosis, and high mitotic activity</td>
<td>Triphasic tumor of adipose and smooth muscle tissue with dysplastic blood vessels, sometimes with cysts lined by flat to hobnailed epithelium</td>
</tr>
<tr>
<td>S-100</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>+</td>
<td>+ (Focal)</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>TLE 1</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>+</td>
<td>−</td>
</tr>
<tr>
<td>EMA</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>+ (Variable)</td>
<td>+</td>
<td>−</td>
</tr>
<tr>
<td>BCL-2</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>+ (Variable)</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>CD34</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>+</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>WT-1</td>
<td>−</td>
<td>−</td>
<td>+ (Epithelial)</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>SMA</td>
<td>+ (Angiodysplastic focus)</td>
<td>+ (Stroma)</td>
<td>−</td>
<td>−</td>
<td>+ (Variable)</td>
<td>−</td>
<td>+</td>
</tr>
<tr>
<td>DESMIN</td>
<td>+ (Angiodysplastic focus)</td>
<td>+ (Stroma)</td>
<td>−</td>
<td>−</td>
<td>+ (Focal)</td>
<td>−</td>
<td>+ (Variable)</td>
</tr>
<tr>
<td>ER/PR</td>
<td>− (Usually)</td>
<td>+ (Stroma)</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>PAX-8</td>
<td>−</td>
<td>−</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>INHIBIN</td>
<td>−</td>
<td>+ (Stroma)</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>CD56</td>
<td>−</td>
<td>−</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
</tr>
<tr>
<td>HMB45</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1066896912453851">
<p>Abbreviations: AMLEC, angiomyolipoma with epithelial cysts; JGH, juxtaglomerular hyperplasia; HPCT, hemangiopericytoma. TLE-1, Transducin-Like Enhancer 1 protein; EMA, epithelial membrane antigen; BCL-2, B-Cell Lymphoma-2 protein; WT-1, Wilm’s tumor 1 protein; SMA, smooth muscle actin; ER/PR, estrogen receptor/progesterone receptor; PAX-8, paired boxed gene 8; HMB45, Human Melanoma Black-45 protein.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-1066896912453851" position="float">
<label>Table 2.</label>
<caption>
<p>Summary of Immunohistochemical Profile</p>
</caption>
<graphic alternate-form-of="table2-1066896912453851" xlink:href="10.1177_1066896912453851-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="2">Stromal Component<hr/></th>
<th align="center" colspan="2">Epithelial Component<hr/></th>
</tr>
<tr>
<th align="center">Positive</th>
<th align="center">Negative</th>
<th align="center">Positive</th>
<th align="center">Negative</th>
</tr>
</thead>
<tbody>
<tr>
<td>ER/PR</td>
<td>Desmin</td>
<td>AE1/AE3</td>
<td>WT-1</td>
</tr>
<tr>
<td>CD34</td>
<td>S-100</td>
<td>CAM5.2</td>
<td>Vimentin</td>
</tr>
<tr>
<td>SMA (perivascular nests only)</td>
<td>WT-1</td>
<td>PAX-2</td>
<td/>
</tr>
<tr>
<td>Vimentin</td>
<td>CD31</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>EMA</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>TLE-1</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>Bcl-2</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>GFAP</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1066896912453851">
<p>Abbreviations: ER/PR, estrogen receptor/progesterone receptor; SMA, smooth muscle actin; WT-1, Wilm’s tumor 1 protein; EMA, epithelial membrane antigen; TLE 1, Transducin-Like Enhancer 1 protein; BCL-2, B-Cell Lymphoma-2 protein; GFAP, glial fibrillary acid protein; AE1/AE3, pankeratin; CAM5.2, keratins 8/18; PAX-8, paired boxed gene 8; HMB45, Human Melanoma Black-45 protein</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Prominent schwannoma-like architecture throughout the tumor (<xref ref-type="fig" rid="fig2-1066896912453851">Figure 2D</xref>) initially suggested an intrarenal schwannoma, a rare tumor with a little more than 20 cases reported in the literature.<sup><xref ref-type="bibr" rid="bibr9-1066896912453851">9</xref></sup> Intrarenal schwannomas are usually centrally located, impinging on the hilum or the pelvis and often benign, with resection being curative. The histological appearance of classic schwannoma is the same irrespective of the organ involved and is characterized by a mixture of Antoni A and Antoni B areas. Cellular schwannoma, on the other hand, is exclusively composed of Antoni A areas without Verocay bodies, a pattern that has been well described in MST.<sup><xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref></sup> The neoplastic cells in schwannoma have diffusely strong cytoplasmic and nuclear expression of S-100 protein. The lack of S-100 expression in our case, combined with the presence of intratumoral angiodysplasia and onion skin collarettes, ruled out an intrarenal schwannoma.</p>
<p>Though not frequently encountered, occasional areas of stroma were seen arranged in short intersecting fascicles, mimicking the appearance of monophasic synovial sarcoma. Additionally, the entrapped renal tubules and intratumoral angiodysplasia initially gave the tumor a biphasic appearance, a feature often encountered in synovial sarcomas. Renal synovial sarcoma is a rare primary mesenchymal tumor of the kidney, with the vast majority of reported cases showing the <italic>SYT-SSX2</italic> fusion gene and exhibiting a monophasic spindle-cell morphology.<sup><xref ref-type="bibr" rid="bibr10-1066896912453851">10</xref></sup> Renal synovial sarcomas are mitotically active high-grade sarcomas associated with necrosis and follow an aggressive course metastasizing frequently to the lungs. In contrast, our case had insignificant mitotic activity, a low proliferation index, no necrosis, a normal karyotype, and lacked expression of both TLE-1 and EMA, all of which are features inconsistent with renal synovial sarcoma.</p>
<p>Solitary fibrous tumor, a distant consideration in the differential diagnosis, has been known to occur rarely in the kidney, with fewer than 20 primary renal cases reported in the literature.<sup><xref ref-type="bibr" rid="bibr11-1066896912453851">11</xref></sup> They are characterized by haphazardly arranged spindle cells of variable cellularity, intercellular deposition of collagen, and “hemangiopericytic” blood vessels and have diffuse expression of CD34 and Bcl-2. Even though our case had areas of hypocellularity and hypercellularity and had diffuse strong expression of CD34, its well-organized architecture and lack of hemangiopericytoma-like vasculature or expression of Bcl-2 was sufficient to exclude solitary fibrous tumor.</p>
<p><italic>PEComas</italic>, a term describing a family of tumors that demonstrates perivascular epithelial cell differentiation, include examples such as lymphangioleiomyomatosis, clear cell “sugar” tumors, and angiomyolipoma.<sup><xref ref-type="bibr" rid="bibr12-1066896912453851">12</xref></sup> Although these tumors can present in various locations, the most common PEComa of the kidney is angiomyolipoma, a triphasic mesenchymal neoplasm with varying amounts of adipose tissue, smooth muscle cells with spindle and/or epithelioid change, and dysplastic blood vessels and affecting women more frequently than men,<sup><xref ref-type="bibr" rid="bibr12-1066896912453851">12</xref>,<xref ref-type="bibr" rid="bibr13-1066896912453851">13</xref></sup> prompting its consideration in the differential diagnosis. Recently, angiomyolipoma with epithelial cysts (AMLEC) have been reported, described as a stromal-predominant tumor with cystic spaces lined by flat to hobnailed pankeratin-positive epithelium, with a subadjacent “cambium-like” condensation of small stromal cells that are intensely positive for melanocytic markers as well as estrogen and progesterone,<sup><xref ref-type="bibr" rid="bibr14-1066896912453851">14</xref>,<xref ref-type="bibr" rid="bibr15-1066896912453851">15</xref></sup> a feature sometimes seen in conventional AMLs.<sup><xref ref-type="bibr" rid="bibr15-1066896912453851">15</xref></sup> Despite these overlapping features between AMLs, AMLECs, and our case, the lack of smooth muscle actin or melanocytic marker expression in the tumor was sufficient to exclude PEComa.</p>
<p>As stated above, our early impression of the tumor was that it was biphasic in nature and that it may represent a MAF, a rare biphasic primary renal tumor predominantly affecting children with a mean age of presentation of 72 months.<sup><xref ref-type="bibr" rid="bibr6-1066896912453851">6</xref>,<xref ref-type="bibr" rid="bibr7-1066896912453851">7</xref></sup> The tumor consists of 2 equally distributed components—an epithelial component that closely resembles MA and a stromal component that closely resembles MST. In our case, the epithelial element was found only at the tumor-renal interface and was thought to represent entrapped renal tubules and not a part of a neoplastic process. Negative expression in these areas for WT-1 and vimentin, combined with strong expression of PAX-2 and cytokeratins, confirmed their nature as nonneoplastic entrapped renal tubules, thus ruling out MAF from the differential.</p>
<p>MEST, a tumor commonly seen in perimenopausal women, was highly considered because of the patient’s postmenopausal status and the observation of ovarian-type stroma and focal phyllodes-like changes.<sup><xref ref-type="bibr" rid="bibr16-1066896912453851">16</xref></sup> Finding estrogen/progesterone-positive stroma (ie, ovarian-type stroma) in a spindle-cell lesion of the kidney with phyllodes-like changes are convincing features for MEST, a tumor that commonly presents in adults between 34 and 78 years of age with a female to male ratio of approximately 8:1, with one quarter of cases having an association with exogenous hormone use.<sup><xref ref-type="bibr" rid="bibr16-1066896912453851">16</xref></sup> MEST, previously referred to as cystic hamartoma of the renal pelvis, leiomyomatous renal hamartoma, and adult mesoblastic nephroma<sup><xref ref-type="bibr" rid="bibr16-1066896912453851">16</xref></sup> and now considered part of a spectrum of cystic renal tumors along with cystic nephroma under the term <italic>renal epithelial stromal tumor</italic>,<sup><xref ref-type="bibr" rid="bibr17-1066896912453851">17</xref>,<xref ref-type="bibr" rid="bibr18-1066896912453851">18</xref></sup> is typically composed of grossly visible cystic and solid areas that express smooth muscle actin, desmin, and often estrogen and progesterone.<sup><xref ref-type="bibr" rid="bibr16-1066896912453851">16</xref><xref ref-type="bibr" rid="bibr17-1066896912453851"/>-<xref ref-type="bibr" rid="bibr18-1066896912453851">18</xref></sup> Despite the stroma expressing estrogen and progesterone, MEST was ruled out after considering the lack of expression of desmin or smooth muscle actin combined with the purely stromal histology. Though cases of stromal predominant MEST have been reported, those lesions were all incidental findings and less than 1 cm in largest dimension.<sup><xref ref-type="bibr" rid="bibr19-1066896912453851">19</xref></sup> Additionally, with ovarian-type stroma, a well-recognized feature in numerous conditions—both neoplastic (eg, mucinous cystic neoplasms of the pancreas) and nonneoplastic (eg, chronic obstructive hydronephrosis)<sup><xref ref-type="bibr" rid="bibr20-1066896912453851">20</xref></sup>—its presence should not preclude a diagnosis of MST and was in fact the basis for designating our case as a “cellular” variant of MST. To our knowledge, only 1 report makes any comment on the estrogen/progesterone reactivity of MST, describing a negative immunophenotype.<sup><xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref></sup></p>
<p>Even though our patient presents outside the commonly reported age range of less than 2 years, several cases of MST have been reported in patients as old as 11 years,<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref></sup> with 4 reports documenting MST presenting in adults (<xref ref-type="table" rid="table3-1066896912453851">Table 3</xref>).<sup><xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref><xref ref-type="bibr" rid="bibr3-1066896912453851"/>-<xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup> Among these adult cases, 2 tumors occurred in elderly men (71 and 77 years old),<sup><xref ref-type="bibr" rid="bibr3-1066896912453851">3</xref></sup> and the other 2 tumors occurred in middle-aged women (53 and 55 years old).<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref>,<xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup> With the exception of 1 case, none of the patients had any tumor history; the one exception was a woman with a 30-year history of Neurofibromatosis, Type I with multiple previous cutaneous excisions, all found to be benign neurofibromas.<sup><xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup> The most common symptom at presentation was abdominal pain (3 of 4 cases),<sup><xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref>,<xref ref-type="bibr" rid="bibr3-1066896912453851">3</xref></sup> with refractory hypertension being the chief symptom in the fourth case.<sup><xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup> Histologically, all 4 cases demonstrated various degrees of intratumoral angiodysplasia and onion-skin tumor collarettes,<sup><xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref><xref ref-type="bibr" rid="bibr3-1066896912453851"/>-<xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup> with only 1 case, the NF patient with refractory hypertension, demonstrating juxtoglomerular hyplerpasia occasionally seen in MST.<sup><xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup> Interestingly, none of the adult cases, including ours, demonstrated heterologous differentiation sometimes seen in MST, usually in the form of glial or cartilaginous elements,<sup><xref ref-type="bibr" rid="bibr1-1066896912453851">1</xref>,<xref ref-type="bibr" rid="bibr6-1066896912453851">6</xref><xref ref-type="bibr" rid="bibr7-1066896912453851"/>-<xref ref-type="bibr" rid="bibr8-1066896912453851">8</xref></sup> which were evaluated using immunohistochemical stains for GFAP and S-100, both of which failed to highlight any tumor elements.</p>
<table-wrap id="table3-1066896912453851" position="float">
<label>Table 3.</label>
<caption>
<p>Adult Metanephric Stromal Tumors</p>
</caption>
<graphic alternate-form-of="table3-1066896912453851" xlink:href="10.1177_1066896912453851-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Case</th>
<th align="center">Age/Sex</th>
<th align="center">Clinical Presentation</th>
<th align="center">Radiological Findings</th>
<th align="center">Macroscopic Findings</th>
<th align="center">Microscopic Findings</th>
<th align="center">IHC Findings</th>
<th align="center">Follow-up</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bluebond-Langner et al (2002)<sup><xref ref-type="bibr" rid="bibr2-1066896912453851">2</xref></sup></td>
<td>53/F</td>
<td>Incidental finding on workup for RUQ pain and biliary colic</td>
<td>Mixed solid cystic right renal mass with mural calcification</td>
<td>5.5-cm Unencapsulated centrally located mass</td>
<td>Bland spindle cells with abundant collagen, onion-skin pattern, and nodular appearance</td>
<td>CD34 pos</td>
<td>None available</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Desmin neg</td>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>ER/PR neg</td>
<td/>
</tr>
<tr>
<td>Amat Villegas et al (2006)<sup><xref ref-type="bibr" rid="bibr3-1066896912453851">3</xref></sup></td>
<td>71/M; 77/M</td>
<td>Abdominal mass with pain</td>
<td>None provided</td>
<td>21- And 18-cm encapsulated masses</td>
<td>Spindle-cell proliferation with subtly infiltrative borders, onion-skin collarettes, intratumoral angiodysplasia with no mitosis or atypia</td>
<td>CD34 pos</td>
<td>Alive and well 4 and 10 years postoperatively</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Vimentin pos</td>
<td/>
</tr>
<tr>
<td>McDonald et al (2011)<sup><xref ref-type="bibr" rid="bibr4-1066896912453851">4</xref></sup></td>
<td>55/F</td>
<td>30-year history of NF-1 with multiple benign cutaneous NFs and new onset of refractory hypertension</td>
<td>Cystic left-lower renal pole mass, suspicious for RCC</td>
<td>2.5-cm Well-circumscribed solid/cystic mass at renal medulla undermining the renal pelvis with calcium oxalate crystals</td>
<td>Bland spindle cells with intracanalicular growth pattern, onion skinning, angiodysplasia, and JGC hyperplasia</td>
<td>CD34 pos</td>
<td>Blood pressure returned to normal status postnephrectomy</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>SMA neg</td>
<td/>
</tr>
<tr>
<td>Chaudhri et al (2012), present case</td>
<td>56/F</td>
<td>Lower-abdominal pain, hematuria</td>
<td>9-cm Mass involving the medulla and impinging into the renal pelvis, undermining the pelvic urothelium</td>
<td>9.0-cm Well-circumscribed unencapsulated mass with focal extension into perinephric fat</td>
<td>Hyperchromatic spindle-cell proliferation with schwanomma-like architecture and cellular, ovarian-type stroma</td>
<td>CD34 pos</td>
<td>Alive and doing well</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>ER/PR pos</td>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>SMA neg</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1066896912453851">
<p>Abbreviations: JGC, juxtaglomerular cell; IHC, immunohistochemistry; pos, positive; neg, negative; RUQ, right upper quadrant; RCC, renal-cell carcinoma.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Although our patient presented outside the typical age range for MST, the combination of intratumoral angiodysplasia, onion-skin tumor collarettes, diffuse expression for CD34, and lack of a neoplastic epithelial component allowed us to conclude that this is a unique and challenging case of MST, unique in its cellular histology and clinical presentation and diagnostically challenging in its apparent biphasic appearance. The tumor’s correct diagnosis was elucidated through extensive histological sampling and immunohistochemical analysis.</p>
</sec>
</body>
<back>
<ack>
<p>We would like to acknowledge Dr Victor Reuter, MD, of Memorial Sloan-Kettering Hospital in New York for providing assistance in diagnosing this case.</p>
</ack>
<fn-group>
<fn fn-type="presented-at">
<label>Authors’ Note</label>
<p>The abstract to this case report was presented at the American Society for Clinical Pathology National Meeting on October 20, 2011, in Las Vegas, NV, USA.</p>
</fn>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896912453851">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Argani</surname><given-names>P</given-names></name>
<name><surname>Beckwith</surname><given-names>JB.</given-names></name>
</person-group> <article-title>Metanephric stromal tumor: report of 31 cases of a distinctive pediatric renal neoplasm</article-title>. <source>Am J of Surg Pathol</source>. <year>2000</year>;<volume>24</volume>:<fpage>917</fpage>-<lpage>926</lpage>.</citation>
</ref>
<ref id="bibr2-1066896912453851">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bluebond-Langner</surname><given-names>R</given-names></name>
<name><surname>Pinto</surname><given-names>PA</given-names></name>
<name><surname>Argani</surname><given-names>P</given-names></name>
<name><surname>Chan</surname><given-names>TY</given-names></name>
<name><surname>Halushka</surname><given-names>M</given-names></name>
<name><surname>Jarrett</surname><given-names>TW.</given-names></name>
</person-group> <article-title>Adult presentation of metanephric stromal tumor</article-title>. <source>J Urol</source>. <year>2002</year>;<volume>168</volume>:<fpage>1482</fpage>-<lpage>1483</lpage>.</citation>
</ref>
<ref id="bibr3-1066896912453851">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Amat Villegas</surname><given-names>I</given-names></name>
<name><surname>Gómez Dorronsoro</surname><given-names>ML</given-names></name>
<name><surname>López Caballero</surname><given-names>MC</given-names></name>
<name><surname>del Llano Varela</surname><given-names>P</given-names></name>
<name><surname>Pascual Piérola</surname><given-names>JI</given-names></name>
<name><surname>Begoña Larrinaga</surname><given-names>M.</given-names></name>
</person-group> <article-title>Tumor Del Estroma Metanéfrico: Presentación De Dos Casos En Adultos Y Revisión De La Literatura [Metanephric stromal tumor: report of two cases and bibliographic review]</article-title>. <source>Arch Esp Urol</source>. <year>2006</year>;<volume>59</volume>:<fpage>88</fpage>-<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr4-1066896912453851">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McDonald</surname><given-names>OG</given-names></name>
<name><surname>Rodriguez</surname><given-names>R</given-names></name>
<name><surname>Bergner</surname><given-names>A</given-names></name>
<name><surname>Argani</surname><given-names>P.</given-names></name>
</person-group> <article-title>Metanephric stromal tumor arising in a patient with neurofibromatosis type 1 syndrome</article-title>. <source>Int J Surg Pathol</source>. <year>2011</year>;<volume>19</volume>: <fpage>667</fpage>-<lpage>671</lpage>.</citation>
</ref>
<ref id="bibr5-1066896912453851">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brancato</surname><given-names>F</given-names></name>
<name><surname>Gurrera</surname><given-names>A</given-names></name>
<name><surname>Bisceglia</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Unclassified pediatric renal stromal tumor overlapping with metanephric stromal tumor and solitary fibrous tumor with diffuse S-100 protein expression</article-title>. <source>Pathol Res Pract</source>. <year>2011</year>;<volume>207</volume>:<fpage>707</fpage>-<lpage>711</lpage>.</citation>
</ref>
<ref id="bibr6-1066896912453851">
<label>6.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Tickoo</surname><given-names>S</given-names></name>
</person-group>. <article-title>Metanpehric tumors: metanephric tumors other than metaadenoma</article-title>. In: <person-group person-group-type="editor">
<name><surname>Amin</surname><given-names>MB</given-names></name>
<name><surname>McKenny</surname><given-names>JK</given-names></name>
<name><surname>Tickoo</surname><given-names>SK</given-names></name>
<etal/>
</person-group>, eds. <source>Diagnostic Pathology: Genitourinary</source>. <publisher-loc>Manitoba, Canada</publisher-loc>: <publisher-name>AmirsysInc</publisher-name>; <volume>2010</volume>:<fpage>140</fpage>-<lpage>143</lpage>.</citation>
</ref>
<ref id="bibr7-1066896912453851">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arroyo</surname><given-names>MR</given-names></name>
<name><surname>Green</surname><given-names>DM</given-names></name>
<name><surname>Perlman</surname><given-names>EJ</given-names></name>
<name><surname>Beckwith</surname><given-names>JB</given-names></name>
<name><surname>Argani</surname><given-names>P.</given-names></name>
</person-group> <article-title>The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study from 25 cases from the National Wilms Tumor Study Group Pathology Center</article-title>. <source>Am J Surg Pathol</source>. <year>2001</year>;<volume>25</volume>:<fpage>433</fpage>-<lpage>444</lpage>.</citation>
</ref>
<ref id="bibr8-1066896912453851">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Argani</surname><given-names>P.</given-names></name>
</person-group> <article-title>Metanephric neoplasms: the hyperdifferentiated, benign end of the Wilms tumor spectrum?</article-title> <source>Clin Lab Med</source>. <year>2005</year>;<volume>25</volume>:<fpage>379</fpage>-<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr9-1066896912453851">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gobbo</surname><given-names>S</given-names></name>
<name><surname>Eble</surname><given-names>JN</given-names></name>
<name><surname>Huang</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Schwannoma of the kidney</article-title>. <source>Mod Pathol</source>. <year>2008</year>;<volume>21</volume>:<fpage>779</fpage>-<lpage>783</lpage>.</citation>
</ref>
<ref id="bibr10-1066896912453851">
<label>10.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Tickoo</surname><given-names>S</given-names></name>
<name><surname>Reuter</surname><given-names>V</given-names></name>
</person-group>. <article-title>Mixed mesenchymal and epithelial tumors: synovial sar</article-title> In: <person-group person-group-type="editor">
<name><surname>Amin</surname><given-names>MB</given-names></name>
<name><surname>McKenny</surname><given-names>JK</given-names></name>
<name><surname>Tickoo</surname><given-names>SK</given-names></name>
<etal/>
</person-group>, eds. <publisher-loc>Diagnostic Pathology</publisher-loc>: <publisher-name>Genitourinary. Manitoba, Canada</publisher-name>: AmirsysInc; <volume>2010</volume>:<fpage>194</fpage>.</citation>
</ref>
<ref id="bibr11-1066896912453851">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fine</surname><given-names>SW</given-names></name>
<name><surname>McCarthy</surname><given-names>DM</given-names></name>
<name><surname>Chan</surname><given-names>TY</given-names></name>
<name><surname>Epstein</surname><given-names>JI</given-names></name>
<name><surname>Argani</surname><given-names>P.</given-names></name>
</person-group> <article-title>Malignant solitary fibrous tumor of the kidney: report of a case and comprehensive review of the literature</article-title>. <source>Arch Pathol Lab Med</source>. <year>2006</year>;<volume>130</volume>:<fpage>857</fpage>-<lpage>861</lpage>.</citation>
</ref>
<ref id="bibr12-1066896912453851">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hornick</surname><given-names>JL</given-names></name>
<name><surname>Fletcher</surname><given-names>CD.</given-names></name>
</person-group> <article-title>PEComa: what do we know so far?</article-title> <source>Histopathology</source>. <year>2006</year>;<volume>48</volume>:<fpage>75</fpage>-<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr13-1066896912453851">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martignoni</surname><given-names>G</given-names></name>
<name><surname>Pea</surname><given-names>M</given-names></name>
<name><surname>Reghellin</surname><given-names>D</given-names></name>
<name><surname>Zamboni</surname><given-names>G</given-names></name>
<name><surname>Bonetti</surname><given-names>F.</given-names></name>
</person-group> <article-title>PEComas: the past, the present and the future</article-title>. <source>Virchows Arch</source>. <year>2008</year>;<volume>452</volume>:<fpage>119</fpage>-<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr14-1066896912453851">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davis</surname><given-names>CJ</given-names></name>
<name><surname>Barton</surname><given-names>JH</given-names></name>
<name><surname>Sesterhenn</surname><given-names>IA.</given-names></name>
</person-group> <article-title>Cystic angiomyolipoma of the kidney: a clinicopathologic description of 11 cases</article-title>. <source>Mod Pathol</source>. <year>2006</year>;<volume>19</volume>:<fpage>669</fpage>-<lpage>674</lpage>.</citation>
</ref>
<ref id="bibr15-1066896912453851">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fine</surname><given-names>SW</given-names></name>
<name><surname>Reuter</surname><given-names>VE</given-names></name>
<name><surname>Epstein</surname><given-names>JI</given-names></name>
<name><surname>Argani</surname><given-names>P.</given-names></name>
</person-group> <article-title>Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma</article-title>. <source>Am J Surg Pathol</source>. <year>2006</year>;<volume>30</volume>:<fpage>593</fpage>-<lpage>599</lpage>.</citation>
</ref>
<ref id="bibr16-1066896912453851">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adsay</surname><given-names>NV</given-names></name>
<name><surname>Eble</surname><given-names>JN</given-names></name>
<name><surname>Srigley</surname><given-names>JR</given-names></name>
<name><surname>Jones</surname><given-names>EC</given-names></name>
<name><surname>Grignon</surname><given-names>DJ.</given-names></name>
</person-group> <article-title>Mixed epithelial and stromal tumor of the kidney</article-title>. <source>Am J Surg Pathol</source>. <year>2000</year>;<volume>24</volume>:<fpage>958</fpage>-<lpage>970</lpage>.</citation>
</ref>
<ref id="bibr17-1066896912453851">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turbiner</surname><given-names>J</given-names></name>
<name><surname>Amin</surname><given-names>MB</given-names></name>
<name><surname>Humphrey</surname><given-names>PA</given-names></name><etal/>
</person-group>. <article-title>Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term</article-title>. <source>Am J Surg Pathol</source>. <year>2007</year>;<volume>31</volume>:<fpage>489</fpage>-<lpage>500</lpage>.</citation>
</ref>
<ref id="bibr18-1066896912453851">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montironi</surname><given-names>R</given-names></name>
<name><surname>Mazzucchelli</surname><given-names>R</given-names></name>
<name><surname>Lopez-Beltran</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity?</article-title> <source>Eur Urol</source>. <year>2008</year>;<volume>54</volume>:<fpage>1237</fpage>-<lpage>1246</lpage>.</citation>
</ref>
<ref id="bibr19-1066896912453851">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parikh</surname><given-names>P</given-names></name>
<name><surname>Chan</surname><given-names>TY</given-names></name>
<name><surname>Epstein</surname><given-names>JI</given-names></name>
<name><surname>Argani</surname><given-names>P.</given-names></name>
</person-group> <article-title>Incidental stromal-predominant mixed epithelial-stromal tumors of the kidney: a mimic of intraparenchymal renal leiomyoma</article-title>. <source>Arch Pathol Lab Med</source>. <year>2005</year>;<volume>129</volume>:<fpage>910</fpage>-<lpage>914</lpage>.</citation>
</ref>
<ref id="bibr20-1066896912453851">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tickoo</surname><given-names>SK</given-names></name>
<name><surname>Gopalan</surname><given-names>A</given-names></name>
<name><surname>Tu</surname><given-names>JJ</given-names></name><etal/>
</person-group>. <article-title>Estrogen and progesterone-receptor-positive stroma as a non-tumorous proliferation in kidneys: a possible metaplastic response to obstruction</article-title>. <source>Mod Pathol</source>. <year>2008</year>;<volume>21</volume>:<fpage>60</fpage>-<lpage>65</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>